• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估癌症患者报告的结局测量指标:可读性及其对临床应用的影响。

Evaluating cancer patient-reported outcome measures: Readability and implications for clinical use.

机构信息

Cancer Health Literacy Research Centre, Cancer Education Program, Princess Margaret Cancer Centre, University Health Network, Cancer Education Program, Toronto, Ontario, Canada.

Patient Education, Cancer Care Ontario, Toronto, Ontario, Canada.

出版信息

Cancer. 2019 Apr 15;125(8):1350-1356. doi: 10.1002/cncr.31928. Epub 2019 Jan 8.

DOI:10.1002/cncr.31928
PMID:30620401
Abstract

BACKGROUND

The benefits of patient-reported outcome measures (PROMs) are well known; however, their readability has come into question because multiple PROMs have been found to be incomprehensible to patients. This is a critical safety and equity consideration because PROMs are increasingly being integrated into routine clinical practice. A key strategy for promoting patient comprehension is the use of plain language. The aim of this study was to determine whether PROMs routinely used in the cancer setting meet plain-language best practices.

METHODS

To report the plain-language level of each PROM, readability (Fry Readability Graph, Simple Measure of Gobbledygook, Flesch Reading Ease, and FORCAST) and understandability assessments (Patient Education Materials Assessment Tool [PEMAT] for Printable Materials) were performed. PROMs at grade level 6 or lower and with PEMAT scores greater than 80% were considered to meet plain-language best practices. PROMs were divided into 4 domains (physical, emotional, social, and quality of life) and 17 dimensions (eg, pain was a dimension of the physical domain). A subanalysis was conducted to determine whether specific domains and dimensions were more likely to adhere to plain-language best practices.

RESULTS

More than half of the 45 PROMs evaluated (n = 33 [73%]) had a grade level higher than 6. Understandability scores ranged from 29% to 100%. The majority of the PROMs that did not meet plain-language best practices were within the physical and emotional domains and focused on the patient's symptom experience.

CONCLUSIONS

This evaluation shows that more than half of the most commonly used cancer PROMs do not meet plain-language best practices. Practice implications include the necessity for plain-language assessment during the PROM validation process, the consideration of plain language in PROM selection, and plain-language review and editing of low-scoring PROMs.

摘要

背景

患者报告结局测量(PROM)的益处是众所周知的;然而,它们的可读性受到了质疑,因为已经发现许多 PROM 让患者难以理解。这是一个至关重要的安全和公平性考虑因素,因为 PROM 越来越多地被纳入常规临床实践。促进患者理解的一个关键策略是使用通俗易懂的语言。本研究的目的是确定在癌症环境中常规使用的 PROM 是否符合通俗易懂的最佳实践。

方法

为了报告每个 PROM 的通俗易懂程度,我们进行了可读性(Fry 可读性图、简单的胡言乱语测量、Flesch 阅读舒适度和 FORCAST)和可理解性评估(用于可打印材料的患者教育材料评估工具[PEMAT])。阅读水平在 6 级或以下且 PEMAT 得分大于 80%的 PROM 被认为符合通俗易懂的最佳实践。PROM 分为 4 个领域(身体、情感、社会和生活质量)和 17 个维度(例如,疼痛是身体领域的一个维度)。进行了一项亚分析,以确定特定的领域和维度是否更有可能符合通俗易懂的最佳实践。

结果

超过一半的 45 个评估的 PROM(n=33 [73%])的阅读水平高于 6 级。可理解性得分范围从 29%到 100%。不符合通俗易懂最佳实践的大多数 PROM 都在身体和情感领域内,并且侧重于患者的症状体验。

结论

这项评估表明,超过一半的最常用的癌症 PROM 不符合通俗易懂的最佳实践。实践意义包括在 PROM 验证过程中进行通俗易懂的评估、在 PROM 选择中考虑通俗易懂的语言以及对低得分 PROM 进行通俗易懂的审查和编辑。

相似文献

1
Evaluating cancer patient-reported outcome measures: Readability and implications for clinical use.评估癌症患者报告的结局测量指标:可读性及其对临床应用的影响。
Cancer. 2019 Apr 15;125(8):1350-1356. doi: 10.1002/cncr.31928. Epub 2019 Jan 8.
2
An effort to improve the collection of patient-generated data: readability and understandability of patient-reported outcomes measures in a survivorship cohort.提高患者生成数据采集的努力:生存队列中患者报告结局测量的可读性和可理解性。
Qual Life Res. 2024 May;33(5):1267-1274. doi: 10.1007/s11136-024-03600-8. Epub 2024 Mar 5.
3
Readability of Patient-Reported Outcome Measures for Head and Neck Oncology.头颈部肿瘤患者报告结局测量的可读性。
Laryngoscope. 2020 Dec;130(12):2839-2842. doi: 10.1002/lary.28555. Epub 2020 Feb 20.
4
Are patient-reported outcome measures in orthopaedics easily read by patients?骨科中患者报告的结局指标对患者来说是否易于理解?
Clin Orthop Relat Res. 2016 Jan;474(1):246-55. doi: 10.1007/s11999-015-4595-0.
5
Readability of Patient-Reported Outcomes in Spine Surgery and Implications for Health Literacy.脊柱手术患者报告结局的可读性及其对健康素养的影响。
Spine (Phila Pa 1976). 2024 Jun 1;49(11):811-817. doi: 10.1097/BRS.0000000000004761. Epub 2023 Jun 27.
6
Readability of Orthopaedic Patient-reported Outcome Measures: Is There a Fundamental Failure to Communicate?骨科患者报告的结局指标的可读性:是否存在沟通的根本障碍?
Clin Orthop Relat Res. 2017 Aug;475(8):1936-1947. doi: 10.1007/s11999-017-5339-0. Epub 2017 Apr 3.
7
Readability of Commonly Used Patient-Reported Outcome Measures in Laryngology.喉科学中常用的患者报告结局测量工具的可读性。
Laryngoscope. 2022 May;132(5):1069-1074. doi: 10.1002/lary.29849. Epub 2021 Sep 9.
8
Patient-Reported Outcome Measures in Voice: An Updated Readability Analysis.语音方面患者报告的结局指标:最新可读性分析
J Voice. 2023 May;37(3):465.e27-465.e34. doi: 10.1016/j.jvoice.2021.01.028. Epub 2021 Mar 16.
9
Can Patients and Families Read the Questionnaires for Patient-related Outcome Measures?患者及其家属能读懂患者相关结局测量的调查问卷吗?
J Pediatr Orthop. 2019 May/Jun;39(5):e397-e401. doi: 10.1097/BPO.0000000000001327.
10
Assessment of online patient education materials from major ophthalmologic associations.主要眼科协会在线患者教育材料评估。
JAMA Ophthalmol. 2015 Apr;133(4):449-54. doi: 10.1001/jamaophthalmol.2014.6104.

引用本文的文献

1
Effects of an Electronic Patient Reported Outcome Measures (e-PROMs) Program on Symptom Reporting, Use of Healthcare, and Overall Survival in Patients With Lymphoma: A Multicenter Prospective Study.电子患者报告结局指标(e-PROMs)项目对淋巴瘤患者症状报告、医疗保健利用及总生存期的影响:一项多中心前瞻性研究
EJHaem. 2025 Sep 3;6(5):e70129. doi: 10.1002/jha2.70129. eCollection 2025 Oct.
2
Early Feedback for the Development of a Novel Brief Colon Cancer Screening Decision Aid for Adults ≥75 years at Risk for Limited Health Literacy: A Pilot Study.针对健康素养有限的75岁及以上有结肠癌筛查风险的成年人开发新型简短结肠癌筛查决策辅助工具的早期反馈:一项试点研究
Cancer Control. 2025 Jan-Dec;32:10732748251372677. doi: 10.1177/10732748251372677. Epub 2025 Aug 28.
3
A health literate evaluation of a reproductive health education program for young men with sickle cell disease.对镰状细胞病青年男性生殖健康教育项目的健康素养评估。
J Commun Healthc. 2025 Apr 11:1-9. doi: 10.1080/17538068.2025.2490419.
4
Improving the Implementation of Patient-Reported Outcome Measure in Clinical Practice: Tackling Current Challenges With Innovative Digital Communication Technologies.改善患者报告结局量表在临床实践中的应用:利用创新数字通信技术应对当前挑战
J Med Internet Res. 2025 Feb 5;27:e60777. doi: 10.2196/60777.
5
Decoding clinical trial jargon: helping people understand how safety and quality of life are assessed in cancer trials.解读临床试验术语:帮助人们了解癌症试验中如何评估安全性和生活质量。
Future Oncol. 2025 Jan;21(1):5-10. doi: 10.1080/14796694.2024.2422808. Epub 2024 Dec 2.
6
Evaluating cancer patient-reported experience measures against health literacy best practices.评估癌症患者报告的体验测量指标与健康素养最佳实践的关系。
Support Care Cancer. 2024 Sep 3;32(10):631. doi: 10.1007/s00520-024-08838-z.
7
Evaluation of online text-based information resources of gynaecological cancer symptoms.妇科癌症症状的在线文本信息资源评估
Cancer Med. 2024 May;13(9):e7167. doi: 10.1002/cam4.7167.
8
An effort to improve the collection of patient-generated data: readability and understandability of patient-reported outcomes measures in a survivorship cohort.提高患者生成数据采集的努力:生存队列中患者报告结局测量的可读性和可理解性。
Qual Life Res. 2024 May;33(5):1267-1274. doi: 10.1007/s11136-024-03600-8. Epub 2024 Mar 5.
9
Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative.评估老年癌症随机临床试验中的患者报告结局(PRO)和患者相关结局:DATECAN-ELDERLY 倡议的结果。
J Geriatr Oncol. 2024 Jan;15(1):101611. doi: 10.1016/j.jgo.2023.101611. Epub 2023 Sep 9.
10
Prediction of morning fatigue severity in outpatients receiving chemotherapy: less may still be more.预测接受化疗的门诊患者晨乏严重程度:少即是多。
Support Care Cancer. 2023 Apr 11;31(5):253. doi: 10.1007/s00520-023-07723-5.